Third Rock Ventures, LLC Company Profile
Third Rock Ventures is a venture capital firm founded in 2007 with the mission to launch transformative life sciences companies. With more than $800 million and two funds under management, the firm is focused on working with passionate entrepreneurs to build exceptional companies working in areas of disruptive science that will make a difference in the lives of patients. The firm has assembled a team with deep expertise and a proven track record of building respected and successful life sciences companies. With decades of complementary, cross-functional operational and leadership experience, the Third Rock team actively engages with its portfolio companies to provide hands-on strategy and experience to successfully launch companies with the best vision, science, operations, people and culture. With offices in Boston, MA and San Francisco, CA, Third Rock is well positioned geographically to closely collaborate with its portfolio companies to achieve their goals. To learn more about Third Rock and its portfolio companies, please visit www.thirdrockventures.com.
News Articles
Third Rock Ventures announce $516 million private financing
Third Rock Ventures announced the final closing of Fund III financing, raising $516 million in an oversubscribed fund. With Fund III, Third Rock will continue to execute on its strategy of launching,...
Third Rock Ventures raises $516M Fund III
Third Rock Ventures, a venture capital firm, announced the final closing of Fund III, raising $516 million in an oversubscribed fund. With Fund III, Third Rock will continue to execute on its strategy...
Rock Spring Ventures launches fund to support life science spin-outs
The UK’s BioIndustry Association (BIA) has welcomed Rock Spring Ventures’ plans to launch a £50 million venture capital fund to invest in life science companies spun out of UK universities. Steve...
Rock Spring Ventures launches L50M EU fund with university support
Rock Spring Ventures said it has secured more than half of a targeted L50 million ($79.2 million) for RSV-EU, a VC fund focused on early stage European life science and health technology companies. Th...
Still Waiting for the Ships to Come in at Third Rock Ventures
Third Rock Ventures was in the enviable position of turning away some institutional investors when the life sciences venture firm recently closed on $516 million for its third venture fund. So first l...
Venture capital: Third Rock Ventures' new $516M fund, investment manifesto and recipe for success
Third Rock Ventures partner Neil Exter tells MassDevice.com about the firm's latest $516 million fund, how it plans to launch -More-
Third Rock Ventures expands, strengthens team
Third Rock Ventures, a venture capital firm focused on building healthcare companies, has expanded and strengthened its team with several appointments and role changes. These additions allow Third Roc...
Third Rock Ventures raises $516 million fund
SAN FRANCISCO, March 25 (Reuters) - Healthcare-oriented venture firm Third Rock Ventures said it had raised a $516 million fund, its third, even as healthcare investing endures something of a slump....
Drugs and Medications
Cyzone [Ventura Corporation Limited]
ROCK YOU cy°zone
Babor body line thermal firming body [Babor Cosmetics America, Corp.]
Body Line Thermal insert
B4 Brands: Avant EX Instant Hand Sanitizer
Avant foaming hand sanitizer [B4 Ventures LLC]
B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free
Avant original instant hand sanitizer [B4 Ventures LLC]
B4 Brands: Avant Original Instant Hand Sanitizer
PubMed Articles
A review of telemedicine business models.
Abstract Telemedicine has become an increasingly popular option for long-distance/virtual medical care and education, but many telemedicine ventures fail to grow beyond the initial pilot stage. Studyi...
CEE-ing is believing: Bioscience ventures in Central and Eastern Europe.
Bioscience ventures in Central and Eastern Europe are becoming a presence in world healthcare markets despite a perennially short supply of venture funding and other support mechanisms relative to oth...
Optimisation of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors.
Rho kinase is an important target implicated in a variety of cardiovascular diseases. Herein, we report the optimisation of the fragment derived ATP-competitive ROCK inhibitors 1 and 2 into lead compo...
RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication.
CDK2-cyclin E triggers centrosome duplication, and nucleophosmin (NPM/B23) is found to be one of its targets. NPM/B23 phosphorylated by CDK2-cyclin E acquires a high binding affinity to Rho-associated...
Hierarchical ZnO Structure with Superhydrophobicity and High Adhesion.
Clinical Trials
Hypothesis: Rho, one of the small GTPase proteins, and its downstream target molecule, Rho-kinase (ROCK), play important roles in mediating various cellular functions, including contractil...
Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis
To evaluate the causal relationship between Rho/Rho kinase overactivity and mechanisms of vascular dysfunction in patients with atherosclerosis.
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)
Vicriviroc (vye-kri-VYE-rock) is an investigational drug (not yet approved by Government Regulatory Authorities for commercial use) that belongs to a new class of drugs, called CCR5 recept...
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)
Vicriviroc (vye-kri-VYE-rock) is an investigational drug (not yet approved by Government Regulatory Authorities for commercial use) that belongs to a new class of drugs, called CCR5 recept...
Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875AM5)
Vicriviroc (vye-kri-VYE-rock) is an investigational drug (not yet approved by Government Regulatory Authorities for commercial use) that belongs to a new class of drugs, called CCR5 recept...
Companies
Third Rock Ventures L.L.C. is a venture firm focused on life sciences, investing and launching companies that make a difference in peopleâs lives. Collaborating with entrepre...
Third Rock Ventures is a venture firm focused on life sciences, investing and launching companies that make a difference in peopleâs lives. Collaborating with entrepreneurs,...
Third Rock Ventures is a venture capital firm founded in 2007 with the mission to launch transformative life sciences companies. With more than $800 million and two funds under ma...
With a total of 162 venues in 52 countries, including 130 cafes and 12 Hotels/Casinos, Hard Rock International is one of the world's most globally recognized brands. Beginning with an Eric Clapton gui...
St. David?s Round Rock Medical Center
St. David's Round Rock Medical Center, located adjacent to downtown Round Rock on FM 620, off of IH-35, provides comprehensive health services to residents of Williamson and surrounding counties. Serv...
More Information about "Third Rock Ventures, LLC" on BioPortfolio
We have published hundreds of Third Rock Ventures, LLC news stories on BioPortfolio along with dozens of Third Rock Ventures, LLC Clinical Trials and PubMed Articles about Third Rock Ventures, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Third Rock Ventures, LLC Companies in our database. You can also find out about relevant Third Rock Ventures, LLC Drugs and Medications on this site too.
